New cancer treatments can be tested in artificial cells on tiny chips the size of a postage stamp
It usually takes 10 to 15 years to develop a new drug, and they cost around US$2.6 billion each. Because it’s difficult to predict how […]
Read more
It usually takes 10 to 15 years to develop a new drug, and they cost around US$2.6 billion each. Because it’s difficult to predict how […]
Read moreOne of the keys to a long life may lie in your net worth. In the first wealth and longevity study to incorporate siblings and […]
Read moreThe American College of Chest Physicians® (CHEST) and Thomas Jefferson University are launching a free online educational program titled "Shared Decision Making in Lung Cancer […]
Read moreDrugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown. Researchers from King's […]
Read moreResearchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers. The National Cancer Institute (NCI) of […]
Read moreAptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announce that they have entered into a […]
Read moreUp to half of patients with head and neck squamous cell carcinoma will experience tumor recurrence or new tumors—tumors that often spread and are difficult […]
Read moreMegin Davies had a mole on the side of her face but as it was small and there were no changes, she thought it was […]
Read moreA new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals. The article, which appears in […]
Read moreA novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma. Using […]
Read more